AR Tool for Post-Surgery Symptoms in Pediatric Cancer Patients
Trial Summary
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Augmented reality (AR), Virtual Reality (VR), Mixed Reality (MR), Extended Reality (XR) for post-surgery symptoms in pediatric cancer patients?
Is augmented reality safe for use in pediatric patients?
How does the AR tool for post-surgery symptoms in pediatric cancer patients differ from other treatments?
The AR tool is unique because it uses augmented reality (AR) to enhance visualization and navigation during surgery, which can help surgeons better detect and remove tumors in pediatric cancer patients. This approach is different from traditional methods as it provides a three-dimensional view of the anatomy, potentially improving surgical outcomes by offering real-time guidance.1291011
What is the purpose of this trial?
The feasibility of using an electronic tool to measure pain, nausea, and vomiting after surgery in English or Spanish-speaking pediatric cancer patients.
Research Team
Juan Cata, MD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for English or Spanish-speaking kids aged 7-17 with cancer who are having surgery lasting over 2 hours and will need painkillers like opioids after. They must be able to understand and use the game in the study, and have a guardian's consent. Kids can't join if their doctor thinks the app isn't right for them or if parents don't agree.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use an AR-based electronic tool to assess postoperative pain, nausea, and vomiting
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Augmented reality (AR)
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Institute of Drug Abuse
Collaborator